U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"The idea that cavalry will be replaced by these iron coaches is absurd. It is little short of treasonous."

Aide-de-camp to Field Marshal Haig ; At a tank demonstration, 1916

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 514/105 - Phosphorus is part of a ring


Subclass of Class 514 - Drug, bio-affecting and body treating compositions
Definition: Subject matter in which a phosphorus atom is part of a ring,
No. of patents: 38
Last issue date: 03/11/2008


NumberTitleIssue Date
7342122Bisphosphonate complexes
Bisphosphonate compounds are disclosed, particularly bisphosonate conjugates useful in the treatment of soft tissues surrounding bone and bone-related diseases, such as bone cancer and osteoporosis. ...
03/11/2008
73324842,4-pyrimidinediamine compounds and their uses
The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a...
02/19/2008
7238377Use of an oil of the gourd family for inhibiting 5 alpha-reductase activity
The invention concerns the use of at least an oil derived from the seeds of the gourd family selected from the group consisting of Lagenaria, Luffa and Momordica, for preparing a composition designed to inhibit 5α-reductase activity, and the use of sa...
07/03/2007
6951844Phenyl naphthol ligands for thyroid hormone receptor
New thyroid receptor ligands are provided which have the general formula I wherein R1 is halogen, trifluoromethyl, substituted or unsubstituted aryl, substituted or ...
10/04/2005
6914056Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
Cyclic glycerophosphates and analogs thereof (CGs) are shown to exert neutral promoting activities in target cells. Such activities include promotion of neuronal outgrowth, promotion of nerve growth, provision of dopaminotrophic supporting envrionment in a diseased ...
07/05/2005
6872712Cyclic glycerophosphates and analogs thereof
Cyclic glycerophosphates as well as some analogs thereof (CGs) are shown to increase phosphorylation of intracellular proteins in various cells. Such activity is not found with linear α or β glycerophosphates. The phosphorylating activity of the CGs render them us...
03/29/2005
6844342Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatm...
01/18/2005
6620816Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide
This invention provides a method of treating a tumor in a warm-blooded animal, including humans, by administering, in combination, an anti-tumor effective amount of tegafur, uracil, folinic acid or pharmaceutically acceptable salt thereof and cyclophospha...
09/16/2003
6552089Method of treating or preventing alopecia
The present application discloses a method of treating alopecia which is based on the use of a tellurium compound such as ammonium trichloro(dioxoethylene-O,O-tellurate)....
04/22/2003
6548488Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
The present invention relates to therapeutic associations for the treatment of cancer, comprising an effective amount of a camptothecin, or a camptothecin derivative, with an effective amount of an alkylating agent, such as melphalan, dacarbazine, or cycl...
04/15/2003
6521606Matrix metalloproteinase inhibitors
A compound of the general formula I ##STR1## wherein Y is O or S; n is 1, 2, 3 or 4; X represents hydroxamic acid, carboxylic acid, phosphonic acid, acetylthiomethyl group or a mercaptomethyl group; R1 is ##STR2## wherein E, when present represents, a bon...
02/18/2003
6514980Nucleoside analogs in combination therapy of herpes simplex infections
A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or penciclorivir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in...
02/04/2003
6509335Benzoxazinoes/benzothiazinones as serine protease inhibitors
This invention discloses benzoxazinone and benzothiazinone compounds which display inhibitory effects on serine proteases such as factor Xa, thrombin, and/or factor VIIa. The invention also discloses pharmaceutically acceptable salts of the compounds, pha...
01/21/2003
6417177Chloroquine derivatives for the treatment of Parkinson's disease
This invention provides compositions and methods for increasing cellular respiration of melanized catecholamine neurons, and methods for alleviating symptoms or stopping appearance and/or progression of symptoms of Parkinson's Disease, and methods for pre...
07/09/2002
6140346Treatment of cancer with thalidomide alone or in combination with other anti-cancer agents
A method is provided for the treatment of neoplastic diseases in a mammal which comprises administering to said mammal a therapeutically effective amount of thalidomide. The method also uses a combination of thalidomide with other anti-neoplastic agents. ...
10/31/2000
5972912Method for lyophilizing ifosfamide
A method of lyophilizing an oxazaphosphorin and a preparation produced thereby including dissolving an oxazaphosphorin in water, adding an amino acid to a molar ratio of between 1 to 10 amino acid to 1 oxazaphosphorin to produce a mixture and lyophilizing...
10/26/1999
5962440Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method
Novel cyclic phosphonate ester inhibitors of MTP are provided which have the structure ##STR1## wherein R2, L2, A, B, L1, R1 and R5a are as set out herein. These compounds are useful in lowering ...
10/05/1999
5958906Phospholipid derivatives containing higher elements of the fifth main group
Phospholipid derivatives containing higher elements of the Vth main group (P, As, Sb, Bi), their method of preparation and antineoplastic and antimicrobially active medications that can be prepared from the phospholipid derivatives....
09/28/1999
5912250Use of immunosuppressive agents for the treatment of schizophrenia
A pharmaceutical composition for the treatment of schizophrenic disorders that comprises a pharmaceutically acceptable carrier and as active ingredient an immunosuppressive agent....
06/15/1999
5712261Method for preventing or treating hypertriglyceridemia
A method is provided for preventing and/or treating hypertriglyceridemia, and/or atherosclerosis and/or pancreatitis resulting from hypertriglyceridemia, employing a squalene synthetase inhibitor....
01/27/1998
5637577Phospholipid derivatives containing higher elements of the fifth group
Phospholipid derivatives containing higher elements of the Vth main group (P, As, Sb, Bi), their method of preparation and antineoplastic and antimicrobially active medications that can be prepared from the phospholipid derivatives....
06/10/1997
5627173Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders
Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders Compounds of the formula I ##STR1## are suitable for producing pharmaceuticals for the treatment and prophylaxis of degenerative joint disorders, of rheumatic di...
05/06/1997
5618804Methanediphosphonic acid derivative, process for production thereof and use for pharmaceuticals
A methane diphosphonic acid derivative represented by the general formula (I): ##STR1## wherein, X and Y are defined in the specification; m represents an integer of 0 to 3; n represents an integer of 0 to 4; and each X of the (X)m an...
04/08/1997
5602115Bisphosphonic acid derivatives as anti-arthritic agents
The bisphosphonates of formula (III) R2 --X--(CW)m1 --CR3 R4 --CH2 --CM[PO--(OR1)2 ]2 (III) bicyclic bisphosphonates (V), and cyclic bisphosphonates (VII...
02/11/1997
5593980Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents
This invention provides a new use of acids, esters, and salts of arylmethylphosphonates of Formula I, ##STR1## or a phosphonic acid of Formula II ##STR2## and derivatives as anti-inflammatory and anti-arthritic agents. Representative compou...
01/14/1997
5536712Bisphosphoryl hydrazines and their use as pesticides
This invention relates to bisphosphoryl hydrazine compounds and to compositions thereof which are useful as pesticides. The compounds of this invention are effective against soil insects, especially the corn rootworm....
07/16/1996
5262149Method of treating or preventing alopecia
A method for treating or preventing alopecia which is induced by an antineoplastic compound is disclosed which is based on the administration of a particular tellurium or selenium derivative to a patient prior to the administration of a antineoplastic age...
11/16/1993
5204335Ifosfamide lyophilisate and process for its preparation
Ifosfamide lyophilizate consisting substantially of ifosfamide and 0.1 to 17 parts by weight of a hexitol....
04/20/1993
5157027Bisphosphonate squalene synthetase inhibitors and method
Compounds which are inhibitors of cholesterol biosynthesis (by inhibiting de novo squalene biosynthesis), and thus are useful as hypocholesterolemic agents and antiatherosclerotic agents are provided which have the structure ##STR1## and analogs...
10/20/1992
5070082Solubilized pro-drugs
The N-phosphorylation of basic nitrogenous drug compounds to produce pro-drugs with enhanced water solubility or lipid solubility, or reduced toxicity, is disclosed. Drugs containing amine, amidine, guadinine, isourea, isothiourea an biguanide functions m...
12/03/1991
5037812Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes
Pharmaceutical compositions and a method for inhibiting the growth of tumor cells by administering a tumor cell growth-inhibiting amount of a bis[bis (diphenylphosphino)hydrocarbon]-, bis[bis(diethylphsophino) hydrocarbon]-, bis[bis(diphenylphosphine-deit...
08/06/1991
4804655Pesticidal cyclic malonylphosphonic diamides
Novel pesticidally active cyclic malonylphosphonic diamides of the formula ##STR1## in which X.sup. represents O or S, R1 represents alkyl, alkenyl, alkinyl, cycloalkyl, aryl or heteroaryl, each of which can be optionally substituted, R2
02/14/1989
4770870Method for reducing pain associated with the administration of 4-sulfido-oxazaphosphorines and 4-sulfoalkylthio-oxazaphorphorines
Through the combined use of a 4-sulfido-oxazaphosphorine of the formula: ##STR1## wherein R1, R2, and R3 are hydrogen, methyl, ethyl, 2-chloroethyl or 2-methanesulfonyloxyethyl and at least two of them are taken from ...
09/13/1988
4695563Arthropodicidal phosphorus-containing heterocycles
Novel arthropodicidally active compounds of the formula ##STR1## in which R represents amino or optionally substituted radicals from the series comprising alkyl, alkylamino, methyl-alkylamino, alkoxy, alkenyloxy and alkylthio, R1 to R...
09/22/1987
4330537Compositions for inhibiting mobilization of calcium phosphate in animal tissue
Compositions for inhibiting the anomalous mobilization of calcium phosphates in animal tissue comprising an effective amount of certain phosphonate compounds as herein defined in combination with Vitamin D-like antirachitic compounds, and a method for tre...
05/18/1982
4278660Complex or salt of a platinum (II) compound and a nitrogen containing polymer
A cis- complex or -salt of a square planar platinum compound and a nitrogen containing oligomer or polymer prepared by reacting a platinum (II) compound with a nitrogen containing oligomer or polymer in an organic solvent or an acidic aqueous medium, said...
07/14/1981
4230700Methods for inhibiting mobilization of calcium phosphate in animal tissue
Compositions for inhibiting the anomalous mobilization of calcium phosphates in animal tissue comprising an effective amount of certain phosphonate compounds as herein defined in combination with Vitamin D-like antirachitic compounds, and a method for tre...
10/28/1980
3984543Therapeutic methods employing cyclic aminophosphonic acids
Therapeutic methods employing cyclic aminophosphonic acids having the formula ##EQU1## wherein R is a member selected from the group consisting of hydrogen and alkyl having from 1 to 6 carbon atoms and n is an integer from 1 to 4; as well as the...
10/05/1976
 
Sign InRegister
Username  
Password   
forgot password?